BESANÇON, France, April 28, 2026
Pixee Medical has announced that its next-generation augmented reality (AR) surgical navigation system, Knee+ NexSight, has received U.S. FDA 510(k) clearance, marking a significant advancement in orthopedic surgical technology and digital health innovation. The clearance enables the company to expand into the U.S. market, particularly targeting ambulatory surgical centers (ASCs) where efficiency, cost-effectiveness, and workflow simplicity are critical.
Built on a new compact AR platform, Knee+ NexSight integrates real-time visualization, voice control, and hands-free operation, offering surgeons enhanced precision and usability during total knee arthroplasty (TKA) procedures. This milestone highlights the growing adoption of AI and augmented reality technologies in regulated medical devices, transforming surgical outcomes and clinical workflows.
Augmented Reality Enhances Surgical Precision and Efficiency
Knee+ NexSight leverages augmented reality guidance to provide robotic-level accuracy without the complexity and cost of traditional robotic systems, enabling surgeons to perform procedures with improved alignment and precision. The system projects a virtual display directly into the surgeon’s field of view, allowing for real-time decision-making without disrupting workflow. Additionally, the integration of voice control technology enables a fully hands-free surgical experience, reducing reliance on additional staff and improving procedural efficiency.
Clinical data indicate that the system may help reduce perioperative blood loss and improve implant positioning, which are critical factors in patient recovery and long-term outcomes. By eliminating disposable components, the system also offers economic and environmental benefits, aligning with healthcare sustainability goals.
Advertisement
Designed for Modern Surgical Environments
The new AR platform has been specifically designed to integrate seamlessly into high-demand surgical environments such as ASCs, where speed, adaptability, and cost control are essential. Its compact and ergonomic design enhances surgeon comfort and mobility, while maintaining compatibility with existing surgical workflows and implant systems. \
Unlike traditional navigation or robotic systems, Knee+ NexSight does not require extensive setup or additional operative time, making it an attractive solution for facilities seeking to improve efficiency without increasing complexity. The system’s ability to support personalized surgical approaches, including kinematic alignment, further enhances its clinical versatility and adoption potential.
Regulatory Milestone and Global Expansion Strategy
The FDA 510(k) clearance follows the system’s earlier CE Mark approval in Europe in February 2026, where it has already been successfully used in clinical procedures. This dual regulatory achievement underscores Pixee Medical’s commitment to meeting stringent global regulatory standards for medical devices, including quality system regulations, software validation, and clinical performance requirements. From a cGxP perspective, the clearance reflects compliance with Good Manufacturing Practice (GMP) principles for device production and regulatory oversight frameworks, ensuring safety, effectiveness, and reliability in clinical use.
Pixee Medical’s innovation represents a broader trend toward digital transformation in surgery, where technologies such as augmented reality and AI are being integrated into clinical practice to enhance precision, reduce variability, and improve patient outcomes. As the demand for minimally invasive and efficient surgical solutions continues to grow, AR-based platforms like Knee+ NexSight are expected to play a central role in the evolution of orthopedic procedures.
With over 10,000 procedures already performed globally using Pixee Medical’s earlier technologies, the company is well-positioned to expand its footprint in the U.S. and international markets. The FDA clearance of Knee+ NexSight not only strengthens its product portfolio but also reinforces its mission to deliver innovative, accessible, and cost-effective surgical solutions that meet the evolving needs of healthcare providers and patients.
Source: Pixee Medical press release
